Skip to main content
OpenTrials

Clinical trial condition

Facio-Scapulo-Humeral Dystrophy

Explore clinical trials studying Facio-Scapulo-Humeral Dystrophy. Study availability and eligibility vary by location and protocol.

10 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Facio-Scapulo-Humeral Dystrophy trial results

Recruiting

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

NCT07038200

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, FSH Muscular Dystrophy, FSHD, +25 more
Locations
  • University of California Irvine Orange, California, United States
  • Stanford University Palo Alto, California, United States
  • University of Colorado Denver, Colorado, United States
  • University of Florida Gainesville, Florida, United States
View all 46 locations
View Trial Details
Recruiting

Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1

NCT06131983

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Facio-Scapulo-Humeral Dystrophy, Genetic Diseases, Inborn, +7 more
Locations
  • Research Site 2 Liverpool, New South Wales, Australia
  • Research Site 3 Auchenflower, Queensland, Australia
  • Research Site 1 Birtinya, Queensland, Australia
  • Research Site 4 Melbourne, Victoria, Australia
View all 17 locations
View Trial Details
Completed

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT05747924

Conditions
Atrophies, Facioscapulohumeral, Atrophy, Facioscapulohumeral, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +33 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • University of California San Diego San Diego, California, United States
  • University of Colorado Denver, Colorado, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT06547216

Conditions
Atrophies, Facioscapulohumeral, Atrophy, Facioscapulohumeral, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +33 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • University of California San Diego San Diego, California, United States
  • University of Colorado Denver, Colorado, United States
View all 17 locations
View Trial Details

Related conditions